KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Research & Development (2009 - 2026)

Abbott Laboratories recorded quarterly Research & Development of $767.0 million in Q1 2026, up 4.35% quarter-over-quarter from $735.0 million in Q4 2025, and up 7.12% year-over-year from $716.0 million in Q1 2025.

Abbott Laboratories' Research & Development history runs 18 years deep, the most recent figure standing at $767.0 million for Q1 2026.

  • In Q1 2026, Research & Development rose 7.12% year-over-year to $767.0 million; the TTM figure through Mar 2026 stood at $3.0 billion (up 4.07% YoY), while the FY2025 annual figure was $2.9 billion, up 3.45% from the prior year.
  • Research & Development came in at $767.0 million for Q1 2026 at Abbott Laboratories, up from $735.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $782.0 million in Q3 2022 to a low of $654.0 million in Q1 2023.
  • A 5-year average of $716.6 million and a median of $715.0 million in 2023 frame the typical range for Research & Development.
  • Across the five-year window, Research & Development increased 16.37% in 2022 and declined 14.07% in 2023, its largest moves.
  • Abbott Laboratories' Research & Development stood at $725.0 million in 2022, then decreased by 3.45% to $700.0 million in 2023, then gained by 7.0% to $749.0 million in 2024, then decreased by 1.87% to $735.0 million in 2025, then climbed by 4.35% to $767.0 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered $767.0 million, $735.0 million, and $766.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 767.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 413.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 722.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 516.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 263.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -461.27 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 145.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 345.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.80 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 103.40 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 767.00 Mn
Dec 31, 2025 735.00 Mn
Sep 30, 2025 766.00 Mn
Jun 30, 2025 725.00 Mn
Mar 31, 2025 716.00 Mn
Dec 31, 2024 749.00 Mn
Sep 30, 2024 713.00 Mn
Jun 30, 2024 698.00 Mn
Mar 31, 2024 684.00 Mn
Dec 31, 2023 700.00 Mn
Sep 30, 2023 672.00 Mn
Jun 30, 2023 715.00 Mn
Mar 31, 2023 654.00 Mn
Dec 31, 2022 725.00 Mn
Sep 30, 2022 782.00 Mn
Jun 30, 2022 684.00 Mn
Mar 31, 2022 697.00 Mn
Dec 31, 2021 762.00 Mn
Sep 30, 2021 672.00 Mn
Jun 30, 2021 654.00 Mn
Mar 31, 2021 654.00 Mn
Dec 31, 2020 698.00 Mn
Sep 30, 2020 580.00 Mn
Jun 30, 2020 564.00 Mn
Mar 31, 2020 578.00 Mn
Dec 31, 2019 595.00 Mn
Sep 30, 2019 596.00 Mn
Jun 30, 2019 577.00 Mn
Mar 31, 2019 672.00 Mn
Dec 31, 2018 562.00 Mn
Sep 30, 2018 574.00 Mn
Jun 30, 2018 575.00 Mn
Mar 31, 2018 589.00 Mn
Dec 31, 2017 619.00 Mn
Sep 30, 2017 568.00 Mn
Jun 30, 2017 520.00 Mn
Mar 31, 2017 553.00 Mn
Dec 31, 2016 368.00 Mn
Sep 30, 2016 352.00 Mn
Jun 30, 2016 348.00 Mn
Mar 31, 2016 379.00 Mn
Dec 31, 2015 369.00 Mn
Sep 30, 2015 378.00 Mn
Jun 30, 2015 345.00 Mn
Mar 31, 2015 313.00 Mn
Dec 31, 2014 361.00 Mn
Sep 30, 2014 305.00 Mn
Jun 30, 2014 310.00 Mn
Mar 31, 2014 369.00 Mn
Dec 31, 2013 359.00 Mn
Sep 30, 2013 339.00 Mn
Jun 30, 2013 363.00 Mn
Mar 31, 2013 346.00 Mn
Dec 31, 2012 377.03 Mn
Sep 30, 2012 350.65 Mn
Jun 30, 2012 370.61 Mn
Mar 31, 2012 363.71 Mn
Dec 31, 2011 -1.47 Bn
Sep 30, 2011 1.01 Bn
Jun 30, 2011 1.04 Bn
Mar 31, 2011 930.40 Mn
Dec 31, 2010 1.06 Bn
Sep 30, 2010 1.08 Bn
Jun 30, 2010 857.70 Mn
Mar 31, 2010 730.37 Mn
Dec 31, 2009 747.05 Mn
Sep 30, 2009 675.74 Mn
Jun 30, 2009 670.21 Mn